Tumors’ alternative energy source could be new target for melanoma therapy

Melanoma tumors switch to an alternative energy system when they develop resistance to chemotherapy, making that alternative system an attractive target for new treatments, according to researchers at Indiana University School of Medicine.

These findings highlight the potential of this enzyme as a novel target for a new anti-melanoma therapy, Dr. Naidu said.

"If we can develop a drug that can effectively inhibit this enzyme, we could extend the life of melanoma patients from months to years," he said.